AMA
Chanda C, Surepalli S. Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2019;14(1):39-47. doi:10.5114/nan.2019.87724.
APA
Chanda, C., & Surepalli, S. (2019). Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, 14(1), 39-47. https://doi.org/10.5114/nan.2019.87724
Chicago
Chanda, Chandrasekhar, and Sobhitha Surepalli. 2019. "Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives". Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology 14 (1): 39-47. doi:10.5114/nan.2019.87724.
Harvard
Chanda, C., and Surepalli, S. (2019). Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, 14(1), pp.39-47. https://doi.org/10.5114/nan.2019.87724
MLA
Chanda, Chandrasekhar et al. "Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives." Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, vol. 14, no. 1, 2019, pp. 39-47. doi:10.5114/nan.2019.87724.
Vancouver
Chanda C, Surepalli S. Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2019;14(1):39-47. doi:10.5114/nan.2019.87724.
